Skip to content

MMWR Morbidity and Mortality Weekly Report

ISSN 0149-2195

2 papers in the library · 9 citations · publishing 2024-2026

Papers

Notes from the Field: Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms — Charlottesville, Virginia, 2023–2024

MMWR Morbidity and Mortality Weekly Report July 18, 2024 Avery Michienzi, Jeremy Hamlin, Rita Farah et al. 9 citations

Since late 2023, gas stations and smoke shops in Virginia have been selling mushroom gummies marketed as nootropics or psychedelics, labeled to contain Amanita muscaria or proprietary mushroom blends. Unlike psilocybin-containing mushrooms, A. muscaria is legal but can cause gastrointestinal upset, agitation, and seizures. Between September 2023 and June 2024, five patients, including one child, were evaluated in Virginia after ingesting such gummies. Because the actual contents are unknown, samples from five brands were tested using liquid chromatography-mass spectrometry.

Severe Illness Associated with Eating Mushroom-Containing Chocolate Products — United States, January–October 2024

MMWR Morbidity and Mortality Weekly Report April 9, 2026 Jelonia T. Rumph, Andrea Winquist, Alyssa N. Troeschel et al.

Eating Diamond Shruumz microdosing chocolate bars was linked to severe poisonings, including higher odds of hospitalization, ICU admission, seizures, and breathing tube placement compared to other mushroom chocolate products. Among 180 cases reported across 34 states from January to October 2024, 73 people were hospitalized, 38 required intensive care, 29 needed intubation, and two died. Eating larger amounts increased the risk. Testing found psychoactive substances such as muscimol, psilocin, and kavalactones in some products. The products were recalled, and consumers were warned of poisoning risks due to variable ingredients and lack of regulatory oversight.